ABIVAX Société Anonyme Soared

Tue, Jun 30, 2026 at 07:39 PM

ABIVAX Société Anonyme (ABVX:NASDAQ) jumped higher at $133.26, representing a gain of 38.6%. On Tue, Jun 30, 2026, ABVX:NASDAQ touched a New 2-Week High of $133.26. The stock got featured on our News Catalysts scanner on Tue, Jun 30, 2026 at 06:46 PM in the 'PUBLIC OFFERING' category. From Tue, Jun 16, 2026, the stock recorded 44.44% Up Days and 50.00% Green Days

About ABIVAX Société Anonyme (ABVX:NASDAQ)

Abivax is focused on developing innovative treatments that harness the body¿s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases.

Top 10 Gainers:

707 Cayman Holdings Limited (JEM:NASDAQ), 267.59%
Lucas GC Limited (LGCL:NASDAQ), 117.21%
Concorde International Group Ltd (YOOV:NASDAQ), 99.48%
Baiya International Group Inc. (BIYA:NASDAQ), 98.23%
Cuprina Holdings (Cayman) Limited (CUPR:NASDAQ), 47.76%
SL Science Holding Limited (SLBT:NASDAQ), 40.88%
ABIVAX Société Anonyme (ABVX:NASDAQ), 38.6%
Globavend Holdings Limited (GVH:NASDAQ), 36.75%
Ambarella, Inc. (AMBA:NASDAQ), 28.04%
Einride AB (ENRD:NASDAQ), 25.36%